
|Videos|April 5, 2021
Lipid Management in 2021 Case Report: Very High-Risk Patient
Author(s)Patrick Campbell
In this segment, panelists discuss their third and final case report. This case features a 63-year-old male classified as a very high-risk patient.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
3
High-Dose Semaglutide Preserves Kidney Function, Reduces Inflammation in Obesity Without Diabetes
4
Berobenatide Monthly Dosing Shows Weight Loss Efficacy in VESPER Trials, With John Buse, MD, PhD
5


























































